VERADIGM INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 29 rows in 2007. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2007-12-13: Reporting owner DAVIS WILLIAM J; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2007-12-13: Reporting owner TULLMAN GLEN; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2007-11-30: Reporting owner LEISHER THOMAS S; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2007-10-02: Reporting owner LEISHER THOMAS S; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2007-12-13 | DAVIS WILLIAM J Officer (Chief Financial Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 108,000 owned after | $3.53 exercise price | 2007-12-14 | |
| 2007-12-13 | TULLMAN GLEN Director, Officer (Chief Executive Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −54,111 0 owned after | $5.63 exercise price | 2007-12-14 | |
| 2007-11-30 | LEISHER THOMAS S Officer (President, eRx) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −30,000 18,111 owned after | $5.63 exercise price | 2007-12-03 | |
| 2007-10-02 | LEISHER THOMAS S Officer (President, eRx) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −12,905 13,845 owned after | $3.53 exercise price | 2007-10-03 | |
| 2007-07-02 | LEISHER THOMAS S Officer (President, eRx) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,250 26,750 owned after | $3.53 exercise price | 2007-07-05 | |
| 2007-04-27 holding as of filing | LEISHER THOMAS S Officer (President, eRx) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $10.67 exercise price | 2007-04-27 | ||
| 2007-04-27 holding as of filing | LEISHER THOMAS S Officer (President, eRx) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $9.49 exercise price | 2007-04-27 | ||
| 2007-04-27 holding as of filing | LEISHER THOMAS S Officer (President, eRx) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $3.53 exercise price | 2007-04-27 | ||
| 2007-04-27 holding as of filing | LEISHER THOMAS S Officer (President, eRx) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $6.75 exercise price | 2007-04-27 | ||
| 2007-04-27 holding as of filing | LEISHER THOMAS S Officer (President, eRx) | 3 | Stock Option (right to buy) Derivative · Direct | Holding | $5.63 exercise price | 2007-04-27 | ||
| 2007-04-03 | TULLMAN GLEN Director, Officer (Chief Executive Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −65,136 206,000 owned after | $3.53 exercise price | 2007-04-04 | |
| 2007-04-03 | DAVIS WILLIAM J Officer (Chief Financial Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −14,041 118,000 owned after | $3.53 exercise price | 2007-04-04 | |
| 2007-04-03 | SHAPIRO LEE Officer (President) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −25,133 51,126 owned after | $3.53 exercise price | 2007-04-04 | |
| 2007-04-03 | CAREY JOSEPH E Officer (Chief Operating Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −27,993 75,625 owned after | $3.15 exercise price | 2007-04-04 | |
| 2007-04-03 | MCGRAW LAURIE Officer (President, Clinical Solutions) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −11,749 59,758 owned after | $3.53 exercise price | 2007-04-04 | |
| 2007-04-02 | TULLMAN GLEN Director, Officer (Chief Executive Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −48,000 0 owned after | $3.15 exercise price | 2007-04-04 | |
| 2007-04-02 | TULLMAN GLEN Director, Officer (Chief Executive Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −53,864 271,136 owned after | $3.53 exercise price | 2007-04-04 | |
| 2007-04-02 | DAVIS WILLIAM J Officer (Chief Financial Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,000 0 owned after | $3.04 exercise price | 2007-04-04 | |
| 2007-04-02 | DAVIS WILLIAM J Officer (Chief Financial Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −17,959 132,041 owned after | $3.53 exercise price | 2007-04-04 | |
| 2007-04-02 | SHAPIRO LEE Officer (President) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −39,304 76,259 owned after | $3.53 exercise price | 2007-04-04 | |
| 2007-04-02 | CAREY JOSEPH E Officer (Chief Operating Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −43,778 103,618 owned after | $3.15 exercise price | 2007-04-04 | |
| 2007-04-02 | MCGRAW LAURIE Officer (President, Clinical Solutions) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −18,372 71,507 owned after | $3.53 exercise price | 2007-04-04 | |
| 2007-03-05 | CULL JOHN G Officer (President, Medication Services) | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 0 owned after | $6.75 exercise price | 2007-03-06 | |
| 2007-02-15 | CAREY JOSEPH E Officer (Chief Operating Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −69,166 0 owned after | $3.00 exercise price | 2007-02-20 | |
| 2007-02-15 | CAREY JOSEPH E Officer (Chief Operating Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,604 147,396 owned after | $3.15 exercise price | 2007-02-20 | |
| 2007-02-15 | SHAPIRO LEE Officer (President) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −64,437 115,563 owned after | $3.53 exercise price | 2007-02-20 | |
| 2007-02-15 | DAVIS WILLIAM J Officer (Chief Financial Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −36,000 4,000 owned after | $3.04 exercise price | 2007-02-20 | |
| 2007-02-15 | TULLMAN GLEN Officer (Chief Executive Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −167,000 48,000 owned after | $3.15 exercise price | 2007-02-20 | |
| 2007-02-15 | MCGRAW LAURIE Officer (President, Clinical Solutions) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −30,121 89,879 owned after | $3.53 exercise price | 2007-02-20 |